Roche 1W Harvesting Gains! Trim Into Strength, Hunt the Next DipRoche (RHHBY) has ripped into the upper region of a rising weekly channel, where I’m looking to sell into strength at the marked resistance zone after this vertical leg.
From there, my plan is to wait for a deeper pullback toward the mid‑channel / prior breakout area to re‑enter on the long side, u
Roche Holding Ltd
No trades
No trades
Compare with Roche Holding Ltd
2.45 USD
15.51 B USD
74.07 B USD
5.51 B
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Thomas Schinecker
Website
Headquarters
Basel
Founded
1896
IPO date
May 4, 2001
ISIN
US7711951043
CUSIP
771195104
FIGI
BBG000BQYTW3
Identifiers
ISIN US7711951043
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Roche Holding: Further UpwardRoche Holding shares have recently continued to rise. In our primary scenario, we see price continuing to head toward our red Short Target Zone between CHF 394.30 and CHF 415.49. We expect the magenta wave (B) to peak within this zone. We then anticipate a significant downward movement in the form o
Roche Strengthens Its Bet Against the “Superbug”By Ion Jauregui – Analyst at ActivTrades
Zosurabalpin: A New Hope Against Antimicrobial Resistance
Swiss pharmaceutical giant Roche (SWX: ROG) has just taken a major step forward in the fight against bacterial resistance: its new antibiotic zosurabalpin is entering Phase 3 clinical trials. The co
Roche Analysis 6/26DISCLOSURE: as of 6/26 I have no open position in SIX:RO
Roche is a Swiss based pharmaceutical conglomerate with a diverse range of operations and brands. The company has a long history of profitability and high returns on investment.
Management Effectiveness: Roche has been around since 1896
Roche: Ready for 120% Growth?We're trying something with Roche here, where we think that we are currently in Wave (5), having recently completed Wave (4). This assessment is better visualized on the daily chart. Hence, we should maintain the 61.8% level for this Wave 4. Anything below would statistically be too low, while above
Roche HoldingsThis is one of those companies you can't afford not to look into. Roche is one of the world's largest biotech companies and a global leader in pharmaceuticals and diagnostics. This leading position translates to strong market share, revenue, and profitability. The company operates across various seg
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateDec 13, 2051
Coupon2.61% (Fixed)
Maturity dateMar 8, 2054
Coupon5.22% (Fixed)
Maturity dateMar 1, 2039
Coupon7.00% (Fixed)
Maturity dateMar 8, 2034
Coupon4.99% (Fixed)
Maturity dateSep 9, 2034
Coupon4.59% (Fixed)
Maturity dateNov 13, 2033
Coupon5.59% (Fixed)
Maturity dateDec 2, 2035
Coupon4.67% (Fixed)
Maturity dateDec 2, 2032
Coupon4.37% (Fixed)
Maturity dateDec 13, 2031
Coupon2.08% (Fixed)
Maturity dateNov 13, 2030
Coupon5.49% (Fixed)
Maturity dateDec 13, 2028
Coupon1.93% (Fixed)
See all RHHBY bonds









